Cost-Effectiveness of Atypical Antipsychotics for the Treatment of Relapse Prevention for Bipolar Disorder: The Russian Perspective

Value in Health- United Kingdom

doi 10.1016/j.jval.2013.03.1585

Full Text

Abstract

Available in

Categories

Occupational Health

Date

May 1, 2013

Authors

Publisher

Elsevier BV

Related search

Atypical Antipsychotics for the Treatment of Disruptive Behavior

Pediatric Annals

English

Psychosocial Interventions for the Prevention of Relapse in Bipolar Disorder: Systematic Review of Controlled Trials

British Journal of Psychiatry

English

Antipsychotics for the Prevention and Treatment of Delirium

English

Cost-Effectiveness Model Comparing Olanzapine and Other Oral Atypical Antipsychotics in the Treatment of Schizophrenia in the United States

Cost Effectiveness and Resource Allocation

English

Both Typical and Atypical Long-Acting Injectable Antipsychotics in Bipolar Disorder: A Retrospective Chart Review

Journal of Mood Disorders

English

Cost-Effectiveness of Antiretroviral Therapy for Prevention

Current HIV Research

Infectious Diseases

English

Prs48 - Cost – Effectiveness Analysis of Vilanterol/Fluticasone Furoate for Asthma Treatment in the Russian Federation

Value in Health

Occupational Health

English

Long-Acting Injectable Antipsychotics as Maintenance Treatments for Bipolar Disorder-A Critical Review of the Evidence

Bipolar Disorders

Biological Psychiatry

English

Metabolic Effects of Treatment With Atypical Antipsychotics

Journal of Clinical Psychiatry

English